Condition: Breast Reconstruction · Sponsor: University of British Columbia
This study is a randomized single blinded prospective clinical trial comparing the surgical outcomes of four different acellular dermal matrixes (ADMs) after primary breast reconstruction. ADMs are used in conjunction with tissue expanders or breast implants to reinforce the recreated breast pocket. Currently, 4 different ADMS are commercially available: AlloDerm, DermaCell, Allomax and Flex HD. It is unclear which ADM is clinically superior. The objective of the study is to compare the complications and post-op care of 4 different ADMs within a 2 year follow up to elucidate their surgical outcomes.
This description comes directly from the study's public registry record.
Dr. Nancy Van Laeken · 604-669-1633 · nancy@vanlaeken.com
Raveena Gowda · raveena.gowda@ubc.ca
Always discuss trial participation with your own doctor first.
| Mount Saint Joseph's Hospital | Vancouver, British Columbia, Canada | Recruiting |
| Vancouver General Hospital | Vancouver, British Columbia, Canada | Recruiting |
| UBC Hospital | Vancouver, British Columbia, Canada | Recruiting |
| Saint Paul's Hospital | Vancouver, British Columbia, Canada | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04661501